市場調查報告書
商品編碼
1273568
到 2028 年的大麻種植市場預測——按產品類型、化合物、應用、分銷渠道、種植類型、生物量、作物品種和地區進行的全球分析Cannabis Cultivation Market Forecasts to 2028 - Global Analysis By Product Type, Compound, Application, Distribution Channel, Cultivation Type, Biomass, Crop Variety and By Geography |
根據 Stratistics MRC 的數據,全球大麻種植市場預計將在 2022 年達到 3921 億美元,並在 2028 年達到 13777 億美元,在預測期內增長 23.3%。預計將以復合年增長率增長的
大麻是一種開花植物,由於其廣泛認可的治療和藥用特性,已經被食用了數千年。 它也因其在社會和精神環境中的使用而聞名。 三個物種佔優勢:C. sativa、C. indica 和 C. ruderalis。 目前正在開發的大多數栽培品種都是結合了這些重要物種的兩種或多種性狀的雜交種。 此外,大麻合法化的運動正在全球範圍內獲得勢頭。 推動這一運動的是人們越來越意識到大麻具有一系列有益的醫學和治療益處。
根據 2021 年 10 月發表在《柳葉刀》雜誌上的一項研究,由於大流行,到 2020 年全球將有 5320 萬例抑鬱症和 7620 萬例焦慮症。
隨著大麻種植和消費在世界許多國家蓬勃發展,技術進步正在改革,以有效地創造基於大麻的產品。 隨著越來越多的國家尋求醫用大麻合法化,技術在大麻種植中的參與變得越來越重要。 傳統上,大麻種植有利於對植物進行少量加工。 然而,技術的進步正在推動生產商越來越多地生產食品、膠囊、電子煙油和軟糖。
大麻合法化帶來了諸如增加就業和增加稅收等好處,但同時也增加了大麻過量服用的風險。 過量服用會導致短期的焦慮和驚恐發作,以及長期的心律失常和精神問題。 還有一種可能是“大麻成癮”,即一次吸食過量的大麻,導致短暫的不良反應。 有許多大麻產品出售,包括膠囊、油、各種食品和蒸發器。 由於奢侈食品的效果需要時間才能顯現,因此意外大量攝入此類奢侈食品的風險更大。 由於這些對健康的負面影響,一些國家尚未使大麻合法化,阻礙了全球大麻產業的發展。
全球大麻需求的快速增長增加了對更好發展的需求。 由於這種需求,多家公司正在開展研發工作,以深入研究大麻的各種基因改造方案。 製造商最有前途的機會之一是為尋求非精神活性醫用大麻的患者創造低劑量、可食用的產品。 此外,低劑量食用品是將新消費者帶入大麻市場的理想產品線,因為可以通過微劑量控制娛樂用途。 大麻注入消費品業務的繁榮是由社會對大麻的接受度不斷提高推動的。
種植大麻需要大量的精力和一致性。 大麻是美國大部分州和其他地區種植的能源消耗量最大的作物之一。 最大化生產需要大量的水和光,以及用於室內和室外植物生長的特殊氣候控制設備。 對水的高需求會導致污染和分流,從而對生態系統產生不利影響。 它還可以直接導致土壤侵蝕。 另一方面,大麻植物可以吸收和儲存重金屬。 能源成本可能達到批發價格的 50%,隨著大麻價格持續下跌,這一數字預計還會上升。
COVID-19 大流行對大麻市場產生了重大影響。 COVID-19 疫情影響了世界各地的多家公司。 大麻市場也是如此。 為了遏制 COVID-19 的傳播,世界各國政府實施了極端限制措施,例如關閉邊境、禁閉和社會隔離。 然而,在後 COVID 形勢下,大麻市場有望受益。
由於大麻和大麻衍生產品的日益普及以及低 THC 水平,預計大麻部分將出現有利增長。 此外,大麻預計將成為增長最快的市場,預計在預測期內將快速擴張。 這種擴張是由於在許多國家,用於醫療和成人使用的大麻日益合法化。
由於大麻和大麻在製藥、個人護理和化妝品、膳食補充劑以及食品和飲料等行業中的使用增加,預計工業消費領域在預測期內將以最快的複合年增長率增長。。 此外,在整個預測期內,公司越來越多地使用大麻及其衍生物作為原料來生產創新的大麻輸液產品等因素預計將提振大麻種植市場。
由於政府法規的快速變化以及烏拉圭和智利等國家休閒大麻的合法化,南美洲預計在預測期內將佔據最大的市場份額。 這種對產品的立法和監管態度的一個重要貢獻者是支持合法化的社會運動。 此外,一些初創公司也開始了產品的研發和生產。
由於醫用大麻使用量的增加和立法發展的進展,預計歐洲在預測期內的複合年增長率最高。 歐洲國家已證明醫用大麻可用於治療一系列疾病,從癌症到艾滋病相關疾病患者的食慾增強。 此外,由於政府政策的變化,預計對該產品的需求將飆升。 因此,由於每個國家的治療應用增加,預計按地區劃分的銷售額將增加。
2022 年 5 月,Canopy Growth Corporation 推出了該公司調味大麻碳酸飲料的新口味:Orange Bit 和 Grape。 此次發布擴大了公司的產品組合,使其能夠在大麻市場提供創新產品。
2022 年 3 月,Martha Stewart 與 Canopy Growth Corporation 和 Marquee Brands 合作推出了 15 種口味的 CBD Wellness Gummi Samplers。 該系列產品為消費者提供了 CBD 的健康益處。
2022年3月,Tilray medicals宣布進入馬耳他共和國市場,並在馬耳他共和國推出首款大麻油產品。 這將使公司能夠擴大其區域影響力。
2021 年 12 月,Organigram Holdings Inc. 收購了加拿大品牌 Laurentian Organics Incorporation,這是一家獲得許可的工藝大麻生產商。 通過這個品牌,我們將有助於獲得強大的客戶群。
2021 年 5 月,Aurora Cannabis Inc. 成立了自己的科學與創新部門,專注於為大麻素生物合成和植物遺傳學的開發申請專利和將專利技術商業化。
2021 年 4 月,Canopy Growth Corporation 將收購 Supreme Cannabis Company,將該公司的優質品牌 7acres 添加到 Canopy Growth 的產品組合中,並增加一個種植低成本雜交溫室大麻的設施。。 此次收購將使公司能夠通過 Supreme 的優質品牌和優質產品接觸更多消費者,進一步加強 Canopy 的市場領導地位。
According to Stratistics MRC, the Global Cannabis Cultivation Market is accounted for $392.1 billion in 2022 and is expected to reach $1377.7 billion by 2028 growing at a CAGR of 23.3% during the forecast period. Cannabis is a genus of flowering plants that has been consumed for thousands of years due of its widely acknowledged therapeutic and medical properties. Its use in social and spiritual contexts is likewise well documented. Three species predominate: C. sativa, C. indica, and C. ruderalis. The majority of cultivars developed now are hybrids that combine traits from two or more of these important species. Additionally, the global movement to legalise marijuana is gathering steam. The main factor fueling this momentum is the growing understanding that the product may have a variety of valid medicinal benefits and therapeutic applications.
According to research published in The Lancet in October 2021, the pandemic resulted in 53.2 million extra significant cases of depressive disorder and 76.2 million additional instances of anxiety disorders worldwide in 2020.
As cannabis cultivation and consumption become more popular in many nations around the world, technological advancement is being reformed to allow for the effective creation of cannabis-based products. As more countries strive to legalise cannabis for medical purposes, technology engagement in cannabis cultivation is becoming increasingly important. Cannabis growers have traditionally prioritised little plant processing. However, due to technical advancements, producers are increasingly focusing on producing edibles, capsules, vaping oils, and gummies.
Legalising cannabis brings benefits in terms of increased employment and tax income, but it also increases the risk of cannabis overdose. Overdosing can cause anxiety or panic attacks in the short term, as well as heart arrhythmia and mental health problems in the long term. Cannabis poisoning, or the transient harmful effects of consuming an excessive amount of cannabis at once, is also a possibility. There are numerous cannabis products available, including capsules, oils, a variety of foods, and vaporizers. Because the effects of edibles take time to manifest, there is a larger danger of mistakenly consuming a high dose of such edibles. As a result of these unfavourable health impacts, several countries are not legalising cannabis, hindering global cannabis industry growth.
The rapid expansion in global demand for cannabis has heightened the need for improved development. As a result of this necessity, several companies have developed R&D that exhaustively investigates various genetic improvement options for cannabis. One of the most promising opportunities for manufacturers is to create low-dose edible products for patients seeking medical cannabis without psychoactive effects. Furthermore, low-dose edibles are an ideal product line for attracting new consumers into the cannabis market because micro-dosing allows them to have control over their recreational usage. The rise of the cannabis-infused consumable products business is being driven by greater social acceptance of cannabis.
Cannabis plant cultivation requires a lot of energy and consistency. Cannabis is one of the most energy-intensive crops growing in the majority of US states and other areas of the world. To maximise output, a large amount of water and light are necessary, as well as specialised climate-control equipment for indoor and outdoor plant growth. The high demand for water causes contamination and diversion, which can harm the ecology. It may also contribute directly to soil erosion. Cannabis plants, on the other hand, have the potential to absorb and store heavy metals. Energy costs might amount to 50% of the wholesale price, which figure is projected to rise as cannabis prices continue to fall.
The COVID-19 pandemic has had a significant impact on the cannabis market. The COVID-19 outbreak has had an impact on a wide range of enterprises worldwide. This is also true in the Cannabis Market. To limit the spread of COVID-19, governments around the world imposed extreme restrictions such as border closures, lockdowns, and social isolation. However, in the post-COVID situation, the cannabis market is expected to benefit.
The hemp segment is estimated to have a lucrative growth, due to the increased popularity of hemp and hemp-derived goods, and because of its low THC concentration. Furthermore, marijuana is predicted to be the fastest-growing market, expanding at a rapid pace during the projection period. This expansion can be ascribed to the increasing legalisation of marijuana for medical and adult use in numerous countries.
The industrial consumption segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increasing use of marijuana and hemp in businesses such as pharmaceuticals, personal care and cosmetics, nutraceuticals, and food and beverages. Furthermore, factors such as the increasing use of cannabis and its derivatives as raw materials by enterprises to create innovative cannabis-infused products are likely to boost the cannabis cultivation market throughout the forecast period.
South America is projected to hold the largest market share during the forecast period owing to fast changing government regulations and the legalisation of recreational hemp in countries such as Uruguay and Chile, among others. Some of the important causes that contributed to this attitude towards the product through laws and legislation were social movements in favour of legalisation. Furthermore, several new start-ups are commencing on product research, development, and production.
Europe is projected to have the highest CAGR over the forecast period, owing to the growing usage of medical cannabis and progressive legislation. Medical marijuana has been shown in trials to be useful in treating illnesses ranging from cancer to appetite stimulants in individuals with AIDS-related sickness in European countries. Furthermore, due to changes in government policy, the product's demand is predicted to skyrocket. As a result, rising therapeutic use of the substance in countries is likely to improve regional sales.
Some of the key players profiled in the Cannabis Cultivation Market include: Atlas Growers, Canopy Growth Corporation, Organigram Holding, Inc., Aphria, Inc., Pacific Cannabis Growers, Aurora Cannabis, The Hydropothecary Corp., Tilray, The Cronos Group, CannTrust Holdings, Better Holdings, Curaleaf, Green Thumb Industries, Cresco Labs, Trulieve and Medmen.
In May 2022, Canopy Growth Corporation launched new flavours for their flavoured cannabis infused carbonated drinks: orange orbit and the Grape. This launch increases the company's product portfolio and delivering innovative products in cannabis market.
In March 2022, Martha Stewart, in collaboration with Canopy Growth Corporation and Marquee Brands, released 15-flavor CBD Wellness Gummies Sampler. This range of products provided the consumer with the wellness benefits of CBD.
In March 2022, Tilray medicals announced their market entry in Malta and launch its first cannabis oil product in Malta. This will help company to expand its regional presence
In December 2021, Organigram Holdings Inc. acquired Laurentian Organics Incorporation, Canadian brand which is a craft cannabis licensed producer. It will help company in acquiring strong customer-based through this brand.
In May 2021, Aurora Cannabis Inc. launched the company's own science & innovation business unit, which mainly focus on commercializing patents and patent technology, with the development of cannabinoid biosynthesis and plant genetics.
In April 2021, Canopy Growth Corporation acquired Supreme Cannabis Company, which leads on to adding their premium brand 7acres to Canopy Growth Portfolio and the facilities of cultivating low-cost hybrid greenhouse cannabis. Due to this acquisition the company can reach more consumers through Supreme's premium brands and high-quality products, further solidifying Canopy's market leadership.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.